Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035542 · ClinicalTrials.gov registry record · Phase 3
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
A Phase 3 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00035542 is a Phase 3 study that has completed, run by Bristol-Myers Squibb.
The verdict
NCT00035542, a Phase 3 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
Interventions
- DRUG glyburide
- DRUG Glucovance (metformin HCl/glyburide)
- DRUG metformin HCl
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-12 |
| Est. Completion | 2003-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035542
The ClinicalTrials.gov registry entry for NCT00035542 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which glyburide is the first listed.
NCT00035542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035542 about?
NCT00035542 is a clinical study titled "A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.". The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
What is the current status of trial NCT00035542?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-12. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00035542?
The interventions under investigation include: glyburide (DRUG), Glucovance (metformin HCl/glyburide) (DRUG), metformin HCl (DRUG).
Who is sponsoring clinical trial NCT00035542?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.